Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 104

1.

Maternal transmission of Alzheimer's disease: prodromal metabolic phenotype and the search for genes.

Mosconi L, Berti V, Swerdlow RH, Pupi A, Duara R, de Leon M.

Hum Genomics. 2010 Feb;4(3):170-93. Review.

2.

Maternal family history of Alzheimer's disease predisposes to reduced brain glucose metabolism.

Mosconi L, Brys M, Switalski R, Mistur R, Glodzik L, Pirraglia E, Tsui W, De Santi S, de Leon MJ.

Proc Natl Acad Sci U S A. 2007 Nov 27;104(48):19067-72. Epub 2007 Nov 14.

3.
4.

Increased fibrillar amyloid-{beta} burden in normal individuals with a family history of late-onset Alzheimer's.

Mosconi L, Rinne JO, Tsui WH, Berti V, Li Y, Wang H, Murray J, Scheinin N, Någren K, Williams S, Glodzik L, De Santi S, Vallabhajosula S, de Leon MJ.

Proc Natl Acad Sci U S A. 2010 Mar 30;107(13):5949-54. doi: 10.1073/pnas.0914141107. Epub 2010 Mar 15.

5.

Amyloid and metabolic positron emission tomography imaging of cognitively normal adults with Alzheimer's parents.

Mosconi L, Rinne JO, Tsui WH, Murray J, Li Y, Glodzik L, McHugh P, Williams S, Cummings M, Pirraglia E, Goldsmith SJ, Vallabhajosula S, Scheinin N, Viljanen T, Någren K, de Leon MJ.

Neurobiol Aging. 2013 Jan;34(1):22-34. doi: 10.1016/j.neurobiolaging.2012.03.002. Epub 2012 Apr 11.

6.
7.

Voxel-based analysis of Alzheimer's disease PET imaging using a triplet of radiotracers: PIB, FDDNP, and FDG.

Shin J, Lee SY, Kim SJ, Kim SH, Cho SJ, Kim YB.

Neuroimage. 2010 Aug 15;52(2):488-96. doi: 10.1016/j.neuroimage.2010.04.013. Epub 2010 Apr 10.

PMID:
20385246
8.

Cholesterol-related genetic risk scores are associated with hypometabolism in Alzheimer's-affected brain regions.

Reiman EM, Chen K, Caselli RJ, Alexander GE, Bandy D, Adamson JL, Lee W, Cannon A, Stephan EA, Stephan DA, Papassotiropoulos A.

Neuroimage. 2008 Apr 15;40(3):1214-21. doi: 10.1016/j.neuroimage.2007.12.066. Epub 2008 Jan 17.

9.

Brain glucose hypometabolism and oxidative stress in preclinical Alzheimer's disease.

Mosconi L, Pupi A, De Leon MJ.

Ann N Y Acad Sci. 2008 Dec;1147:180-95. doi: 10.1196/annals.1427.007. Review.

10.

FDG- and amyloid-PET in Alzheimer's disease: is the whole greater than the sum of the parts?

Mosconi L, McHugh PF.

Q J Nucl Med Mol Imaging. 2011 Jun;55(3):250-64. Review.

11.

Association between GAB2 haplotype and higher glucose metabolism in Alzheimer's disease-affected brain regions in cognitively normal APOEε4 carriers.

Liang WS, Chen K, Lee W, Sidhar K, Corneveaux JJ, Allen AN, Myers A, Villa S, Meechoovet B, Pruzin J, Bandy D, Fleisher AS, Langbaum JB, Huentelman MJ, Jensen K, Dunckley T, Caselli RJ, Kaib S, Reiman EM.

Neuroimage. 2011 Feb 1;54(3):1896-902. doi: 10.1016/j.neuroimage.2010.09.066. Epub 2010 Oct 1. Erratum in: Neuroimage. 2011 Oct 1;58(3):974.

12.

Maternal age affects brain metabolism in adult children of mothers affected by Alzheimer's disease.

Mosconi L, Tsui W, Murray J, McHugh P, Li Y, Williams S, Pirraglia E, Glodzik L, De Santi S, Vallabhajosula S, de Leon MJ.

Neurobiol Aging. 2012 Mar;33(3):624.e1-9. doi: 10.1016/j.neurobiolaging.2011.03.003. Epub 2011 Apr 22.

13.

Hypometabolism in Alzheimer-affected brain regions in cognitively healthy Latino individuals carrying the apolipoprotein E epsilon4 allele.

Langbaum JB, Chen K, Caselli RJ, Lee W, Reschke C, Bandy D, Alexander GE, Burns CM, Kaszniak AW, Reeder SA, Corneveaux JJ, Allen AN, Pruzin J, Huentelman MJ, Fleisher AS, Reiman EM.

Arch Neurol. 2010 Apr;67(4):462-8. doi: 10.1001/archneurol.2010.30.

14.

Preclinical sporadic Alzheimer's disease: target for personalized diagnosis and preventive intervention.

Vanitallie TB.

Metabolism. 2013 Jan;62 Suppl 1:S30-3. doi: 10.1016/j.metabol.2012.08.024. Epub 2012 Sep 26. Review.

PMID:
23021038
15.

Higher serum total cholesterol levels in late middle age are associated with glucose hypometabolism in brain regions affected by Alzheimer's disease and normal aging.

Reiman EM, Chen K, Langbaum JB, Lee W, Reschke C, Bandy D, Alexander GE, Caselli RJ.

Neuroimage. 2010 Jan 1;49(1):169-76. doi: 10.1016/j.neuroimage.2009.07.025. Epub 2009 Jul 23.

16.

Quantitative longitudinal interrelationships between brain metabolism and amyloid deposition during a 2-year follow-up in patients with early Alzheimer's disease.

Förster S, Yousefi BH, Wester HJ, Klupp E, Rominger A, Förstl H, Kurz A, Grimmer T, Drzezga A.

Eur J Nucl Med Mol Imaging. 2012 Dec;39(12):1927-36. doi: 10.1007/s00259-012-2230-9. Epub 2012 Aug 28.

PMID:
22926714
17.

Maternal family history is associated with Alzheimer's disease biomarkers.

Honea RA, Vidoni ED, Swerdlow RH, Burns JM; Alzheimer’s Disease Neuroimaging Initiative.

J Alzheimers Dis. 2012;31(3):659-68. doi: 10.3233/JAD-2012-120676.

18.

Fluoro-2-deoxy-D-glucose (FDG)-PET in APOEepsilon4 carriers in the Australian population.

Rimajova M, Lenzo NP, Wu JS, Bates KA, Campbell A, Dhaliwal SS, McCarthy M, Rodrigues M, Paton A, Rowe C, Foster JK, Martins RN.

J Alzheimers Dis. 2008 Mar;13(2):137-46.

PMID:
18376055
19.

Alzheimer's disease: genetic basis and amyloid imaging as endophenotype.

Berti V, Nacmias B, Bagnoli S, Sorbi S.

Q J Nucl Med Mol Imaging. 2011 Jun;55(3):225-36. Review.

PMID:
21532537
20.

Reduced gray matter volume in normal adults with a maternal family history of Alzheimer disease.

Honea RA, Swerdlow RH, Vidoni ED, Goodwin J, Burns JM.

Neurology. 2010 Jan 12;74(2):113-20. doi: 10.1212/WNL.0b013e3181c918cb.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk